MTI introduces doctor targeting tool

Share this article:
DTP marketer MTI has launched a new multi-channel communication product. Titled Director, the product assesses physician prescribing patterns and other characteristics to determine the most effective way to deliver marketing materials, including drug samples.

“We look at doctors' individual characteristics, and decide each week who to target. Director starts by identifying those physicians responsible for generating 80% of a brand's volume,” says Anthony Bianciella, VP, marketing, at MTI. Other characteristics, such as how a doctor interacts with sales reps, how he or she distributes samples and whether or not the doctor's practice is growing, are also collected and measured. “We then use that information to decide how to reach the doctor, whether it's telemarketing, telesales, emails, or drug samples,” says Bianciella.

Bianciella says Director, like a really good sales rep who knows his doctor, can communicate on that same level. “Many times sales reps use drug samples just to get in the door [to see physicians]. We decide what makes sense based on the data, and that isn't necessarily samples. We're not going to throw samples at doctors—we use them where they'll have the most impact and most benefit.”
Director is based on a “communication matrix” developed by MTI that utilizes “letters, emails, telemarketing scripts and samples in conjunction with brands and agencies.”
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...